Heart rate control and its predictors in patients with heart failure and sinus rhythm: data from the European Society of Cardiology Long-Term Registry
![Thumbnail](/dspace/bitstream/handle/2183/37194/Tyminska_Heart_2023.pdf.jpg?sequence=5&isAllowed=y)
Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/37194
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC-BY-NC-ND 4.0)
Coleccións
- INIBIC-ICATC - Artigos [174]
Metadatos
Mostrar o rexistro completo do ítemTítulo
Heart rate control and its predictors in patients with heart failure and sinus rhythm: data from the European Society of Cardiology Long-Term RegistryAutor(es)
Data
2022-08-17Cita bibliográfica
Tymińska A, Ozierański K, Wawrzacz M, Balsam P, Maciejewski C, Kleszczewska M, Zawadzka M, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Opolski G, Grabowski M, Kapłon-Cieślicka A. Heart rate control and its predictors in patients with heart failure and sinus rhythm: data from the European Society of Cardiology Long-Term Registry . Cardiol J. 2022 Aug 17;30(6):964–73.
Resumo
[Abstract]
Background: Higher resting heart rate (HR) in patients with heart failure (HF) and sinus rhythm (SR) is associated with increased mortality. In patients hospitalized for HF, the aim herein, was to assess the use and dosage of guideline-recommended HR lowering medications, HR control at discharge and predictors of HR control.
Methods: In the present study, were Polish participants of the European Society of Cardiology HF Long-Term (ESC-HF-LT) Registry. Those selected were hospitalized for HF, with reduced ejection fraction (HFrEF) and SR at discharge (n = 236). The patients were divided in two groups ( < 70 and ≥ 70 bpm). Logistic regression was used to identify the predictors of HR ≥ 70 bpm.
Results: Of patients with HFrEF and SR, 59% had HR ≥ 70 bpm at hospital discharge. At discharge, 96% and only 0.5% of the patients with HFrEF and SR received beta-blocker and ivabradine, respectively. In the HF groups < 70 and ≥ 70 bpm, only 11% and 4% of patients received beta-blocker target doses, respectively. There was no difference in the use of other guideline-recommended medications. Age, New York Heart Association class, HR on admission and lack of HR lowering medications were predictors of discharge HR ≥ 70 bpm.
Conclusions: Heart rate control after hospitalization for HFrEF is unsatisfactory, which may be attributed to suboptimal doses of beta-blockers, and negligence in use other HR lowering drugs (including ivabradine).
Palabras chave
Acute heart failure
Beta blocker
Hospitalization
Ivabradine
Sinus rhythm
Target heart rate
Beta blocker
Hospitalization
Ivabradine
Sinus rhythm
Target heart rate
Versión do editor
Dereitos
Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC-BY-NC-ND 4.0)
ISSN
1897-5593